Legislation – Victims and Prisoners Act 2024
Changes to legislation:
Victims and Prisoners Act 2024, Section 49 is up to date with all changes known to be in force on or before 20 October 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Changes and effects yet to be applied to the whole Act associated Parts and Chapters:
Whole provisions yet to be inserted into this Act (including any effects on those provisions):
- s. 66(1)(2)s. 66(3)(a)–(e)(i)(f)(4)(5) coming into force by S.I. 2024/966 reg. 3(1)(a)
Part 3Infected blood compensation
I149Infected blood compensation scheme
1
The Secretary of State or the Minister for the Cabinet Office must by regulations within three months of the passing of this Act establish a scheme (the “infected blood compensation scheme”) for making payments to eligible persons.
2
“Eligible persons” means such persons within subsection (3) as the regulations provide are to be eligible persons.
3
The persons within this subsection are persons who—
a
have been infected as a result of being treated with blood, blood products or tissue,
b
have been infected as a result of another person being treated with blood, blood products or tissue, or
c
have been affected by another person being infected as described in paragraph (a) or (b).
4
The regulations may define an eligible person by reference to matters including (but not limited to)—
a
the kind of infection;
b
the duration or effect of an infection;
c
when the treatment occurred;
d
where the treatment was given;
e
who gave the treatment;
f
whether a person was treated with blood, blood products or tissue;
g
5
The regulations must provide for payments under the scheme to be made by, and the scheme to be otherwise administered by, the IBCA.